Ery-Ped 400 mg/5mL
Erythromycin Ethylsuccinate · SUSPENSION · Carnegie Pharmaceuticals LLC
Ery-Ped is a suspension containing erythromycin ethylsuccinate at 400 mg/5mL, taken oral. Manufactured by Carnegie Pharmaceuticals LLC.
Key Facts
- Brand Name
- Ery-Ped
- Generic Name
- Erythromycin Ethylsuccinate
- NDC Code (Product)
80005-155- Manufacturer
- Carnegie Pharmaceuticals LLC
- Strength
- 400 mg/5mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA050207
- Marketing Start
- 01/15/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Ery-Ped used for?
Ery-Ped contains Erythromycin Ethylsuccinate. It is a suspension taken oral. Consult your doctor for specific uses.
Is Ery-Ped a controlled substance?
Ery-Ped is not classified as a controlled substance by the DEA.
What is the generic name for Ery-Ped?
The generic name for Ery-Ped is Erythromycin Ethylsuccinate. There are 10 other brand versions of Erythromycin Ethylsuccinate.
What is the NDC code for Ery-Ped 400 mg/5mL?
The NDC (National Drug Code) for Ery-Ped 400 mg/5mL is 80005-155, listed by Carnegie Pharmaceuticals LLC.
Other Ery-Ped Dosages
Other Erythromycin Brands
See all →- Erythromycin Ethylsuccinate400 mg/5mL75834-294
- E.E.S200 mg/5mL80005-152
- Erythromycin ethylsuccinate400 mg/5mL85742-030
- Erythromycin Ethylsuccinate200 mg/5mL75834-295
- Erythromycin Ethylsuccinate200 mg/5mL52536-134
- Erythromycin ethylsuccinate200 mg/5mL71209-102
- E.E.S200 mg/5mL24338-134
- Erythromycin Ethylsuccinate200 mg/5mL62559-630
- E.E.S 400400 mg/180005-161
- Erythromycin ethylsuccinate200 mg/5mL85742-029
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)